Throat Sprays Global Market Report 2025

The throat spray market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.01 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%.

Key drivers behind this historical growth include an increased incidence of seasonal flu and common colds, rising consumer focus on hygiene and self-care, broader access to over-the-counter remedies, a growing preference for natural and herbal solutions, and a surge in throat irritations caused by pollutants and allergens.

The throat spray market size is expected to see strong growth in the next few years. It will grow to $1.25 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%.

Factors contributing to this projected growth include heightened global health awareness, an aging population more prone to throat infections, expanding e-commerce and direct-to-consumer healthcare channels, growing investments in research and development for specialized formulations, and an increasing number of respiratory conditions, particularly post-viral throat complications. Anticipated market trends include innovations in spray delivery mechanisms, fusion of botanical and pharmaceutical components, personalized healthcare driven by technology, emergence of alcohol-free and preservative-free sprays, and progress in cold-chain logistics and product packaging.

The increasing incidences of respiratory infections are expected to propel the growth of the throat sprays market going forward. Respiratory infections refer to infectious diseases that affect any part of the respiratory system, including the sinuses, throat, airways, and lungs. The rise in respiratory infections is largely attributed to increasing air pollution, which weakens respiratory defenses and makes individuals more susceptible to infections. Throat sprays help alleviate symptoms of respiratory infections by delivering soothing and anti-inflammatory ingredients directly to the throat for rapid relief. Many of these sprays also contain antimicrobial agents that support infection control and promote faster healing. For example, in June 2024, the UK Health Security Agency reported that from week 40 of 2022 to week 15 of 2023, there were 1,681 critical care admissions for confirmed influenza across 108 NHS trusts in England. This was a significant increase compared to 182 admissions by 114 trusts in the previous season, with the number rising to 316 by week 39 of 2022. Therefore, the growing number of respiratory infections is driving demand for throat sprays.

Major companies in the throat spray market are prioritizing the development of products such as homeopathic throat sprays to improve throat care and deliver effective symptom relief. These sprays utilize highly diluted natural ingredients to address throat discomfort by encouraging the body’s self-healing abilities. Known for being gentle and free from synthetic chemicals, homeopathic throat sprays are used to relieve soreness, irritation, or hoarseness. For instance, in October 2024, Boiron, a US-based homeopathic product manufacturer, launched the ThroatCalm line, including ThroatCalm Spray. This product is designed to provide targeted relief for occasional minor sore throat pain and features plant-based active ingredients like Echinacea and Plantago major. With a mint-like herbal flavor, the spray delivers a cooling mist without the numbing effects associated with benzocaine. It is now available at Sprouts Farmers Market and Vitamin Shoppe locations.

In April 2022, Galen Pharma, a UK-based provider of oral spray for treating oral mucositis (OM) - a painful inflammation of the mouth and throat lining - formed a partnership with Sunstar Suisse S.A. to enhance patient quality of life through advanced supportive care. This collaboration aims to broaden Galen’s product range and increase the availability of GelX Oral Spray for cancer patients experiencing oral mucositis in the UK and Ireland. The initiative focuses on improving patient outcomes through enhanced supportive oncology care. Sunstar Suisse S.A. is a Switzerland-based company that delivers high value-added products and services across the oral care, health, and cosmetics sectors.

Major players in the throat sprays market are Walgreens, Procter & Gamble, Johnson & Johnson, Reckitt Benckiser Group, Prestige Consumer Healthcare Inc., Aboca S.P.A., Nature’s Way, Eu Yan Sang, Apivita, Specchiasol, Wedderspoon, Iscon Life Sciences Private Limited, Power Health, Intra Life Private Limited, Innoram Biogenics, Watsons, Lanes, Roots Healthcare, AGAN UK, ReBoost.

Throat sprays are medicinal products formulated to deliver a fine mist directly to the throat, providing quick relief from irritation, inflammation, and soreness caused by dryness, infections, or allergies. These sprays help alleviate discomfort and pain while supporting the healing process. Their targeted application ensures fast and convenient symptom management, making them a practical solution for throat-related issues.

Throat sprays are categorized into several types, including anti-inflammatory sprays, anesthetic sprays, pain relief sprays, antibacterial sprays, and those made with natural extracts. Anti-inflammatory throat sprays offer focused relief by minimizing pain and inflammation using NSAIDs and are frequently combined with anesthetics or antiseptics to enhance soothing effects and fight infections. These sprays are available in diverse formulations such as herbal, alcohol-free, sugar-free, and honey-based options. They come with various dispensing technologies, including long-nozzle applicators and advanced mist systems. Distribution takes place through multiple channels, including drugstores, retail outlets, hospital pharmacies, and online platforms, and they are commonly used for conditions like sore throats, colds, coughs, and other related ailments.

The throat sprays market research report is one of a series of new reports that provides throat sprays market statistics, including the throat sprays industry global market size, regional shares, competitors with the throat sprays market share, detailed throat sprays market segments, market trends, opportunities, and any further data you may need to thrive in the throat sprays industry. This throat sprays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

North America was the largest region in the throat sprays market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in throat sprays report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the throat sprays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The throat sprays market consists of sales of antiviral throat sprays, antifungal throat sprays, and decongestant throat sprays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by their creators.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.